Blueberries Medical Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BBRRF research report →
About the company
Blueberries Medical Corp. conducts comprehensive operations in Colombia, covering the entire process of medicinal cannabis and its derivative products—from their initial cultivation and development to final production and distribution. The company specializes in providing pharmaceutical-grade cannabis oil extracts along with other associated therapeutic products.
- CEO
- Facundo Garreton
- IPO
- 2019
- Employees
- 5
- HQ
- Bogotá, CO
Price Chart
- Market Cap
- $5.30M
- P/E
- -4.68
- P/S
- 16.51
- P/B
- 29.33
- EV/EBITDA
- -7.31
- Div Yield
- 0.00%
- Gross Margin
- 34.12%
- Op Margin
- -257.68%
- Net Margin
- -352.85%
- ROE
- -192.35%
- ROIC
- -194.93%
- Revenue
- $312.03K · -33.81%
- Net Income
- $-1,664,502 · -44.92%
- EPS
- $-0.00 · -17.24%
- Op Income
- $-1,377,831.2
- FCF YoY
- -55.87%
- 52W High
- $0.02
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 2.64
- Avg Volume
- 30.45K
Get TickerSpark's AI analysis on BBRRF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our BBRRF coverage
Recent articles, reports, and earnings notes.
No research on BBRRF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BBRRF report →Similar companies
Peers in the same neighborhood.